WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

Detalles Bibliográficos
Autores principales: Batiha, Gaber El-Saber, Al-Gareeb, Dr. Ali I., Qusti, Safaa, Alshammari, Eida M., Rotimi, Damilare, Adeyemi, Oluyomi Stephen, Al-kuraishy, Hayder M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. on behalf of African Institute of Mathematical Sciences Next Einstein Initiative 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683381/
https://www.ncbi.nlm.nih.gov/pubmed/34957352
http://dx.doi.org/10.1016/j.sciaf.2021.e01084
_version_ 1784617405426696192
author Batiha, Gaber El-Saber
Al-Gareeb, Dr. Ali I.
Qusti, Safaa
Alshammari, Eida M.
Rotimi, Damilare
Adeyemi, Oluyomi Stephen
Al-kuraishy, Hayder M.
author_facet Batiha, Gaber El-Saber
Al-Gareeb, Dr. Ali I.
Qusti, Safaa
Alshammari, Eida M.
Rotimi, Damilare
Adeyemi, Oluyomi Stephen
Al-kuraishy, Hayder M.
author_sort Batiha, Gaber El-Saber
collection PubMed
description This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
format Online
Article
Text
id pubmed-8683381
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V. on behalf of African Institute of Mathematical Sciences Next Einstein Initiative
record_format MEDLINE/PubMed
spelling pubmed-86833812021-12-20 WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer Batiha, Gaber El-Saber Al-Gareeb, Dr. Ali I. Qusti, Safaa Alshammari, Eida M. Rotimi, Damilare Adeyemi, Oluyomi Stephen Al-kuraishy, Hayder M. Sci Afr Article This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal. Elsevier B.V. on behalf of African Institute of Mathematical Sciences Next Einstein Initiative 2021-12-18 /pmc/articles/PMC8683381/ /pubmed/34957352 http://dx.doi.org/10.1016/j.sciaf.2021.e01084 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Batiha, Gaber El-Saber
Al-Gareeb, Dr. Ali I.
Qusti, Safaa
Alshammari, Eida M.
Rotimi, Damilare
Adeyemi, Oluyomi Stephen
Al-kuraishy, Hayder M.
WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
title WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
title_full WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
title_fullStr WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
title_full_unstemmed WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
title_short WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
title_sort withdrawn: common nlrp3 inflammasome inhibitors and covid-19: divide and conquer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683381/
https://www.ncbi.nlm.nih.gov/pubmed/34957352
http://dx.doi.org/10.1016/j.sciaf.2021.e01084
work_keys_str_mv AT batihagaberelsaber withdrawncommonnlrp3inflammasomeinhibitorsandcovid19divideandconquer
AT algareebdralii withdrawncommonnlrp3inflammasomeinhibitorsandcovid19divideandconquer
AT qustisafaa withdrawncommonnlrp3inflammasomeinhibitorsandcovid19divideandconquer
AT alshammarieidam withdrawncommonnlrp3inflammasomeinhibitorsandcovid19divideandconquer
AT rotimidamilare withdrawncommonnlrp3inflammasomeinhibitorsandcovid19divideandconquer
AT adeyemioluyomistephen withdrawncommonnlrp3inflammasomeinhibitorsandcovid19divideandconquer
AT alkuraishyhayderm withdrawncommonnlrp3inflammasomeinhibitorsandcovid19divideandconquer

Ejemplares similares